| Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp X Qiu, G Wong, J Audet, A Bello, L Fernando, JB Alimonti, ... Nature 514 (7520), 47-53, 2014 | 1228 | 2014 |
| Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection J Dyall, CM Coleman, T Venkataraman, MR Holbrook, J Kindrachuk, ... Antimicrobial agents and chemotherapy 58 (8), 4885-4893, 2014 | 739 | 2014 |
| Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques GG Olinger Jr, J Pettitt, D Kim, C Working, O Bohorov, B Bratcher, E Hiatt, ... Proceedings of the National Academy of Sciences 109 (44), 18030-18035, 2012 | 456 | 2012 |
| Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis J Kindrachuk, B Ork, S Mazur, MR Holbrook, MB Frieman, D Traynor, ... Antimicrobial agents and chemotherapy 59 (2), 1088-1099, 2015 | 410 | 2015 |
| FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection LM Johansen, JM Brannan, SE Delos, CJ Shoemaker, A Stossel, C Lear, ... Science translational medicine 5 (190), 190ra79-190ra79, 2013 | 382 | 2013 |
| Evaluation of candidate vaccine approaches for MERS-CoV L Wang, W Shi, MG Joyce, K Modjarrad, Y Zhang, K Leung, CR Lees, ... Nature communications 6 (1), 7712, 2015 | 336 | 2015 |
| Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge KL Warfield, DL Swenson, GG Olinger, WV Kalina, MJ Aman, S Bavari The Journal of infectious diseases 196 (Supplement_2), S430-S437, 2007 | 327 | 2007 |
| Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail J Pettitt, L Zeitlin, DH Kim, C Working, JC Johnson, O Bohorov, B Bratcher, ... Science translational medicine 5 (199), 199ra113-199ra113, 2013 | 291 | 2013 |
| Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays J Dyall, E Postnikova, H Zhou, J Kindrachuk, RF Johnson, GG Olinger Jr, ... Journal of general virology 95 (3), 571-577, 2014 | 281 | 2014 |
| Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant L Zeitlin, J Pettitt, C Scully, N Bohorova, D Kim, M Pauly, A Hiatt, L Ngo, ... Proceedings of the National Academy of Sciences 108 (51), 20690-20694, 2011 | 274 | 2011 |
| Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study DV Clark, H Kibuuka, M Millard, S Wakabi, L Lukwago, A Taylor, MA Eller, ... The Lancet Infectious Diseases 15 (8), 905-912, 2015 | 264 | 2015 |
| CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates NJ Sullivan, L Hensley, C Asiedu, TW Geisbert, D Stanley, J Johnson, ... Nature medicine 17 (9), 1128-1131, 2011 | 264 | 2011 |
| A screen of approved drugs and molecular probes identifies therapeutics with anti–Ebola virus activity LM Johansen, LE DeWald, CJ Shoemaker, BG Hoffstrom, ... Science translational medicine 7 (290), 290ra89-290ra89, 2015 | 258 | 2015 |
| Middle East respiratory syndrome and severe acute respiratory syndrome: current therapeutic options and potential targets for novel therapies J Dyall, R Gross, J Kindrachuk, RF Johnson, GG Olinger Jr, LE Hensley, ... Drugs 77 (18), 1935-1966, 2017 | 226 | 2017 |
| Structures of protective antibodies reveal sites of vulnerability on Ebola virus CD Murin, ML Fusco, ZA Bornholdt, X Qiu, GG Olinger, L Zeitlin, ... Proceedings of the National Academy of Sciences 111 (48), 17182-17187, 2014 | 216 | 2014 |
| Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers KL Warfield, DL Swenson, GG Olinger, DK Nichols, WD Pratt, R Blouch, ... PLoS pathogens 2 (1), e1, 2006 | 198 | 2006 |
| Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection CJ Shoemaker, KL Schornberg, SE Delos, C Scully, H Pajouhesh, ... PloS one 8 (2), e56265, 2013 | 171 | 2013 |
| Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization X Ji, GG Olinger, S Aris, Y Chen, H Gewurz, GT Spear Journal of General Virology 86 (9), 2535-2542, 2005 | 165 | 2005 |
| Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection KL Warfield, G Olinger, EM Deal, DL Swenson, M Bailey, DL Negley, ... The Journal of Immunology 175 (2), 1184-1191, 2005 | 158 | 2005 |
| Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by marburg and ebola viruses M Mohamadzadeh, SS Coberley, GG Olinger, WV Kalina, G Ruthel, ... Journal of virology 80 (14), 7235-7244, 2006 | 149 | 2006 |
